Protein arrays: Applications and implications in neuroscience;Matrices de proteínas: Aplicaciones e implicaciones en neurociencia

Revista de Neurologia

Volumn 44, Issue 5, 2007, Pages 285-290

  Leis Esnaola, Olatz ^a   Lafuente Sanchez J V ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Antibody protein array; Biomarker; Neuroscience; Protein analysis; Protein profile; Proteomic

Indexed keywords

BIOLOGICAL MARKER; ANTIBODY;

COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); EARLY DIAGNOSIS; GENOMICS; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; METHODOLOGY; MORPHOLOGY; NEUROSCIENCE; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MICROARRAY; PROTEIN STRUCTURE; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; VALIDATION PROCESS; HUMAN; INSTRUMENTATION; METABOLISM; REPRODUCIBILITY; UTILIZATION REVIEW;

ANTIBODIES; BIOLOGICAL MARKERS; HUMANS; NEUROSCIENCES; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 34447256600     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4405.2006384     Document Type: Review

References (49)

1. Marcotte EM. Measuring the dynamics of the proteome. Genome Res 2001; 11: 191-3.
2. McCarthy JE. Posttranscriptional control of gene expression in yeast. Microbiol Mol Biol Rev 1998; 62: 1492-553.
3. Parekh RB, Rohlff C. Post-translational modification of proteins and the discovery of new medicine. Curr Opin Biotechnol 1997; 8: 718-23.
4. Kettman JR, Coleclough C, Frey JR, Lefkovits I. Clonal proteomics: one gene-family of proteins. Proteomics 2002; 2: 624-31.
5. Ge H. UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions. Nucleic Acids Res 2000; 28: e3.
6. Ekins R. Measurement of free hormones in blood. Endocr Rev 1990; 11: 5-46.
7. Ekins R, Chu FW. Microarrays: their origins and applications. Trends Biotechnol 1999; 17: 217-8.
8. Haab BB, Dunham MJ, Brown PO. Protein microarrays for highly parallel detection and quantization of specific proteins and antibodies in complex solutions. Genome Biol 2001; 2: RESEARCH0004.
9. Kusnezow W, Hoheisel JD. Antibody microarrays: promises and problems. Biotechniques 2002; Suppl: 14-23.
10. Harry JL, Wilkins MR, Herbert BR, Packer NH, Gooley AA, Williams KL. Proteomics: capacity versus utility. Electrophoresis 2000; 21: 1071-81.
11. Forrer P, Stumpp MT, Binz HK, Pluckthun A. A novel strategy to design binding molecules harnessing the modular nature of repeat proteins. FEBS Lett 2003; 539: 2-6.
12. Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci U S A 2000; 97: 9390-5.
13. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999; 17: 994-9.
14. Madoz-Gurpide J, Wang H, Misek DE, Brichory F, Hanash SM. Protein based microarrays: a tool for probing the proteome of cancer cells and tissues. Proteomics 2001; 1: 1279-87.
15. Espejo A, Cote J, Bednarek A, Richard S, Bedford MT. A protein-domain microarray identifies novel protein-protein interactions. Biochem J 2002; 367: 697-702.
16. Paweletz CP, Liotta LA, Petricoin EF III. New technologies for biomarker analysis of prostate cancer progression: laser capture microdissection and tissue proteomics. Urology 2001; 57: 160-3.
17. Liotta LA, Kohn EC, Petricoin EF III. Clinical proteomics: personalized molecular medicine. JAMA 2001; 286: 2211-4.
18. Zhu H, Bilgin M, Bangham R, Hall D, Casamayor A, Bertone P, et al. Global analysis of protein activities using proteome chips. Science 2001; 293: 2101-5.
19. Cahill DJ. Protein and antibody arrays and their medical applications. J Immunol Methods 2001; 250: 81-91.
20. MacBeath G. Protein microarrays and proteomics. Nat Genet 2002; 32 (Suppl): 526-32.
21. Kodadek T. Protein microarrays: prospects and problems. Chem Biol 2001; 8: 105-15.
22. Lueking A, Cahill DJ, Mullner S. Protein biochips: a new and versatile platform technology for molecular medicine. Drug Discov Today 2005; 10: 789-94.
23. Mendoza LG, McQuary P, Mongan A, Gangadharan R, Brignac S, Eggers M. High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA). Biotechniques 1999; 27: 778-80, 782-6, 788.
24. Moody MD, Van Arsdell SW, Murphy KP, Orencole SF, Burns C. Array-based ELISAs for high-throughput analysis of human cytokines. Biotechniques 2001; 31: 186-90, 192-4.
25. Poetz O, Schwenk JM, Kramer S, Stoll D, Templin MF, Joos TO. Protein microarrays: catching the proteome. Mech Ageing Dev 2005; 126: 161-70.
26. Huang RP. Detection of multiple proteins in an antibody-based protein microarray system. J Immunol Methods 2001; 255: 1-13.
27. Nielsen UB, Cardone MH, Sinskey AJ, MacBeath G, Sorger PK. Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc Natl Acad Sci U S A 2003; 100: 9330-5.
28. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR. Making antibodies by phage display technology. Annu Rev Immunol 1994; 12: 433-55.
29. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990; 348: 552-4.
30. Hanes J, Pluckthun A. In vitro selection and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci U S A 1997; 94: 4937-42.
31. Holt LJ, Bussow K, Walter G, Tomlinson IM. By-passing selection: direct screening for antibody-antigen interactions using protein arrays. Nucleic Acids Res 2000; 28: E72.
32. Holt LJ, Enever C, De Wildt RM, Tomlinson IM. The use of recombinant antibodies in proteomics. Curr Opin Biotechnol 2000; 11: 445-9.
33. Nam MJ, Madoz-Gurpide J, Wang H, Lescure P, Schmalbach CE, Zhao R, et al. Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics 2003; 3: 2108-15.
34. Qiu J, Madoz-Gurpide J, Misek DE, Kuick R, Brenner DE, Michailidis G, et al. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J Proteome Res 2004; 3: 261-7.
35. Kusnezow W, Hoheisel JD. Solid supports for microarray immunoassays. J Mol Recognit 2003; 16: 165-76.
36. Vijayendran RA, Leckband DE. A quantitative assessment of heterogeneity for surface-immobilized proteins. Anal Chem 2001; 73: 471-80.
37. Espina V, Woodhouse EC, Wulfkuhle J, Asmussen HD, Petricoin EF III, Liotta LA. Protein microarray detection strategies: focus on direct detection technologies. J Immunol Methods 2004; 290: 121-33.
38. Angenendt P, Glokler J, Murphy D, Lehrach H, Cahill DJ. Toward optimized antibody microarrays: a comparison of current microarray support materials. Anal Biochem 2002; 309: 253-60.
39. Joos TO, Schrenk M, Hopfl P, Kroger K, Chowdhury U, Stoll D, et al. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 2000; 21: 2641-50.
40. Leis O, Bulnes S, Bengoetxea H, Azkona G, Gutiérrez E, Lafuente JV. Perfil proteico diferencial en astrocitomas humanos mediante matrices de anticuerpos [abstract]. Rev Neurol 2005; 41 (Supl 2): 81.
41. Ho L, Sharma N, Blackman L, Festa E, Reddy G, Pasinetti GM. From proteomics to biomarker discovery in Alzheimer's disease. Brain Res Brain Res Rev 2005; 48: 360-9.
42. Vercauteren FG, Bergeron JJ, Vandesande F, Arckens L, Quirion R. Proteomic approaches in brain research and neuropharmacology. Eur J Pharmacol 2004; 500: 385-98.
43. Schonberger SJ, Edgar PF, Kydd R, Faull RL, Cooper GJ. Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics 2001; 1: 1519-28.
44. D'Ascenzo M, Relkin NR, Lee KH. Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach. Curr Opin Mol Ther 2005; 7: 557-64.
45. Davidsson P, Sjogren M. The use of proteomics in biomarker discovery in neurodegenerative diseases. Dis Markers 2005; 21: 81-92.
46. Butterfield DA, Castegna A. Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders. Amino Acids 2003; 25: 419-25.
47. Xiao Z, Prieto D, Conrads TP, Veenstra TD, Issaq HJ. Proteomic patterns: their potential for disease diagnosis. Mol Cell Endocrinol 2005; 230: 95-106.
48. Zabel C, Klose J. Influence of Huntington's disease on the human and mouse proteome. Int Rev Neurobiol 2004; 61: 241-83.
49. Zabel C, Chamrad DC, Priller J, Woodman B, Meyer HE, Bates GP, et al. Alterations in the mouse and human proteome caused by Huntington's disease. Mol Cell Proteomics 2002; 1: 366-75.